Product Details for ANDA 090514
TRAZODONE HYDROCHLORIDE (TRAZODONE HYDROCHLORIDE)
50MG
Marketing Status: Discontinued
100MG
Marketing Status: Discontinued
150MG
Marketing Status: Discontinued
300MG
Marketing Status: Discontinued
50MG
Marketing Status: Discontinued
Active Ingredient: TRAZODONE HYDROCHLORIDE
Proprietary Name: TRAZODONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A090514
Product Number: 001
Approval Date: Jun 2, 2009
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
TRAZODONE HYDROCHLORIDE (TRAZODONE HYDROCHLORIDE)
Proprietary Name: TRAZODONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A090514
Product Number: 001
Approval Date: Jun 2, 2009
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
100MG
Marketing Status: Discontinued
Active Ingredient: TRAZODONE HYDROCHLORIDE
Proprietary Name: TRAZODONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A090514
Product Number: 002
Approval Date: Jun 2, 2009
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
TRAZODONE HYDROCHLORIDE (TRAZODONE HYDROCHLORIDE)
Proprietary Name: TRAZODONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A090514
Product Number: 002
Approval Date: Jun 2, 2009
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
150MG
Marketing Status: Discontinued
Active Ingredient: TRAZODONE HYDROCHLORIDE
Proprietary Name: TRAZODONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A090514
Product Number: 003
Approval Date: Jun 2, 2009
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
TRAZODONE HYDROCHLORIDE (TRAZODONE HYDROCHLORIDE)
Proprietary Name: TRAZODONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A090514
Product Number: 003
Approval Date: Jun 2, 2009
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
300MG
Marketing Status: Discontinued
Active Ingredient: TRAZODONE HYDROCHLORIDE
Proprietary Name: TRAZODONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A090514
Product Number: 004
Approval Date: Jun 2, 2009
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: TRAZODONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A090514
Product Number: 004
Approval Date: Jun 2, 2009
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information